(Q36409960)

14 August 2017

1 reference

title

The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas (English)

1 reference

14 August 2017

Pamela Hodul

1

1 reference

14 August 2017

Mokenge Malafa

series ordinal

2

1 reference

14 August 2017

Junsung Choi

series ordinal

3

1 reference

14 August 2017

Larry Kvols

series ordinal

4

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

13

1 reference

14 August 2017

1

1 reference

14 August 2017

61-71

1 reference

Neuroendocrine gastrointestinal tumours

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Karnofsky memorial lecture. An odyssey in the land of small tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Treatment of the carcinoid tumor and the malignant carcinoid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Hepatic resection for metastatic colorectal cancer results in cure for some patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Angiographic classification of hepatic arterial collaterals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Management of neuroendocrine liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

The management of patients with advanced carcinoid tumors and islet cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Ablative therapies for liver metastases of digestive endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Neuroendocrine metastases of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Radiofrequency ablation of malignant liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Radiofrequency ablation treatment of refractory carcinoid hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Interferon in the management of neuroendocrine GEP-tumors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480601300109

10.1177/107327480601300109

21 January 2018

Identifiers

DOI

0 references

1 reference